Product Data Sheet

KRFK

Catalog No. A84887

main product photo
KRFK is a TGF-β agonist peptide derived from thrombospondin-1 (TSP-1) that activates the TGF-β pathway. This compound enhances TGF-β-mediated signaling and its downstream effects, operating independently of TSP receptors, including CD47 and CD36. KRFK is ideally suited for research applications involving chronic ocular surface inflammatory disorders.
Chemical Information
Catalog NumA84887
M. Wt577.72
FormulaC27H47N9O5
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.162290-78-0
Synonyms
SMILES[C@@H](CC1=CC=CC=C1)(NC([C@@H](NC([C@H](CCCCN)N)=O)CCCNC(=N)N)=O)C(N[C@@H](CCCCN)C(O)=O)=O
Biological Activity
DescriptionKRFK is a TGF-β agonist peptide derived from thrombospondin-1 (TSP-1) that activates the TGF-β pathway. This compound enhances TGF-β-mediated signaling and its downstream effects, operating independently of TSP receptors, including CD47 and CD36. KRFK is ideally suited for research applications involving chronic ocular surface inflammatory disorders.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.